| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Executive Officer
1 company
Jeffrey S. Hackman is Chief Executive Officer at FENC. Jeffrey S. Hackman's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $758K at current prices.
Net of sales, the FENC filings show accumulation of 15,000 shares.
Jeffrey S. Hackman has 13 Form 4 filings on record from August 2024 to October 2026, all as Chief Executive Officer at Fennec Pharmaceuticals (FENC), 2024–2026.
The 18 reported transactions were 7 stock awards, 5 option exercises, 4 option or other derivative awards and 2 open-market purchases.
Counted by filing, the open-market trades come to 1 purchase worth about $105K and no sales.
The only open-market purchase was 15,000 shares of FENC at an average $6.97 on May 19, 2025, about $105K. Twelve months later FENC was up 28%.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 19, 2025 | FENC Fennec Pharmaceuticals Inc. | Chief Executive Officer | Buy | 15,000 | $6.97 | $104,601.60 | New | +7.2% | +27.6% |